Clinical trial
Efficacy of Customized Corneal Cross-linking Versus Standard Corneal Cross-linking in Patients With Progressive Keratoconus
NCT04532788 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Customized Corneal Cross-linking Versus Standard Corneal Cross-linking in Patients With Progressive Keratoconus
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 1, 2021
- Completion date
- June 5, 2024
- Enrollment
- 124 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.